James G. Onder
St. Louis, MO (PRWEB) June 24, 2014
Attorneys representing national Testim lawsuits announce an expansion of their website, the Testim Testosterone Lawsuit Center, in response to a new FDA testosterone warning*. News broke late last week that the FDA will require testosterone drug makers to expand the warning featured on drug labels for testosterone replacement drugs including Testim.
The June 19, 2014 FDA testosterone warning features information on health risks that have been only recently associated with testosterone drugs such as Testim. The new warning label contents constitute an expansion of the current warnings regarding dangerous blood clots that can result from testosterone replacement therapies.
Testim is one among several testosterone replacement therapies that have been approved by the FDA for use in treating persons suffering from medical conditions related to hypogonadism. Hypogonadism is defined by a lack of serum testosterone made by the testicles, commonly resulting from genetic problems and chemotherapy, among other causes. Hypogonadism is diagnosed via a blood test; only persons who suffer from diagnosed hypogonadism and a resulting medical condition are approved to take Testim.
In two separate FDA testosterone warnings, the federal agency has now cautioned patients and medical practitioners of the dangers of arterial and venous blood clots as a side effect of testosterone replacement therapy. On January 31, 2014, the FDA cited new research** stating that patients taking testosterone may face a higher risk for heart attack, stroke, and cardiovascular conditions caused by arterial blood clots. An ongoing investigation was launched to determine the efficacy of testosterone heart attack and stroke risks.
The June 19, 2014 FDA testosterone warning addresses a new set of testosterone dangers – venous blood clots. According to the FDA testosterone warning, blood clots in the veins can result in serious health problems such as deep vein thrombosis and pulmonary embolism. These conditions had previously been thought only to stem from polycythemia, or an increase in red blood cells from testosterone drugs including Testim. The new FDA warning indicates that men using testosterone drugs like Testim are prone to venous blood clots in general, even in the absence of polycythemia.
To date, testosterone lawsuits*** that have received national publicity are those that have been filed for arterial blood clot problems such as heart attack and stroke. Testim lawsuits filed in U.S. District Courts will be considered as part of a national multi-district litigation (MDL) in the Northern Illinois U.S, District Court in Chicago, Case MDL 2545. Testim lawsuits, as well as other testosterone lawsuits, are being compiled under In re: Testosterone Replacement Therapy Products Liability Litigation. These consolidated Testim lawsuits will only consider complaints regarding conditions caused by arterial blood clots, such as heart attack and stroke.
The Testim Testosterone Lawsuit Center website is a comprehensive public resource provided by national product and family safety attorneys at The Onder Law Firm. Located in St. Louis, this testosterone lawyer group is distinguished by its success representing individuals against large entities in major pharmaceutical, product liability, and personal injury lawsuits. Individuals who believe they may have grounds to file a Testim testosterone lawsuit related to heart attack or stroke may contact the firm for a free testosterone lawsuit case review by completing an online contact form at the firm’s website.
No amount of money can compensate families effectively for the loss of loved one, but filing a Testim lawsuit may help bring about an increase in consumer safety accountability. Lawyers representing clients in Testim cases at The Onder Law Firm believe qualifying persons may be entitled to real compensation by filing a Testim lawsuit. Attorneys handling national Testim lawsuits offer no-cost, no-obligation case review to persons or family members of those who have suffered heart attack, stroke, or another serious health problem possibly related to Testim. Interested persons may contact the firm via its Testim Testosterone Lawsuit Center website.
The Onder Law Firm welcomes Testim lawsuit or other testosterone case inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from Testim attorneys at http://www.TestimTestosteroneLawsuitCenter.com.
*fda.gov/drugs/drugsafety/ucm401746.htm
**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm
***jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf